Paul Wearing

The power and limits of zeroing in

A health-care revolution in the making

A sampler of diagnostics emerging from Stanford

Doubts mount over move to end off-label drug oversight

New drug approvals ebb; doubts over testing's gold standard grow

The human subjects trade is booming, largely without oversight

Serving in clinical trials offers lessons for living

Why nothing really is something, and in some ways is better than anything

Musings on why evidence can persuade, but a good story compels

Minds of all kinds join to hasten discoveries of new medical treatments